Form 4: MannKind Director Michael Friedman Receives RSU Grant

Director Michael A. Friedman was granted 82,781 restricted stock units by MannKind Corporation on May 20, 2026.

Summary

• Director Michael A. Friedman received a grant of 82,781 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of MannKind common stock.
• The RSUs vested on May 20, 2026.
• Delivery of the underlying shares is deferred until the director separates from service on the board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None noted.

Risks

• Future dilution of existing shareholders upon the eventual issuance of common stock related to these RSUs.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure director alignment with company performance in the biotechnology sector.

Comparison to Industry Standards

• The use of deferred-delivery RSUs for board members is a common practice among mid-cap biotech firms to retain board talent.
• The grant size is consistent with standard director compensation packages for companies of similar market capitalization.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor potential for future dilution upon share delivery.

Next Steps

• Issuance of common stock upon the director's future separation from the board.

Key Dates

Keywords

MannKind, MNKD, Form 4, Insider Trading, Director Compensation, Restricted Stock Units